Government of Canada signs bilateral agreement with Alberta to improve access to drugs for rare diseases
The bilateral agreement with Alberta under the National Strategy for Drugs for Rare Diseases will invest $162 million to improve access to selected drugs for rare diseases, and to support enhanced access to early diagnosis and screening.